期刊
CANCER AND METASTASIS REVIEWS
卷 22, 期 4, 页码 301-307出版社
SPRINGER
DOI: 10.1023/A:1023726827771
关键词
EGFR; HER; signaling; therapy; cancer; review
类别
资金
- NCI NIH HHS [CA65746, CA088923, CA80066, CA 80066] Funding Source: Medline
Activating mutations, gene amplification and overexpression of human epidermal growth factor receptor (erbB or HER) family kinases have been implicated as integral contributors to a variety of cancers. However, there is increasing evidence that the HER family receptors propagate not only signals initiated by their own ligands but also those initiated by multiple other signaling pathways. Attenuation of HER family signaling is a developing strategy for the management of human malignancies and is the subject of a number of ongoing clinical trials. The purpose of this review is to provide a timely update of recent reports in the rapidly evolving area of HER family biology and the emerging integral role of these receptors in malignant transformation and as targets of cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据